Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects
出版年份 2013 全文链接
标题
Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects
作者
关键词
-
出版物
Obesity
Volume 21, Issue 7, Pages 1335-1342
出版商
Wiley
发表日期
2013-05-13
DOI
10.1002/oby.20208
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes
- (2011) Janne Prawitt et al. Current Diabetes Reports
- Alterations of Hormonally Active Fibroblast Growth Factors after Roux-en-Y Gastric Bypass Surgery
- (2011) Peter L.M. Jansen et al. DIGESTIVE DISEASES
- The Effect of Very-Low-Calorie Diet on mRNA Expression of Inflammation-Related Genes in Subcutaneous Adipose Tissue and Peripheral Monocytes of Obese Patients with Type 2 Diabetes Mellitus
- (2011) M. Mraz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance
- (2010) Tim C. M. A. Schreuder et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism
- (2010) Gemma Brufau et al. HEPATOLOGY
- Bile acid malabsorption in inflammatory bowel disease
- (2010) Martin Lenicek et al. INFLAMMATORY BOWEL DISEASES
- Bariatric surgery: Mechanisms, indications and outcomes
- (2010) Paul E O'Brien JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- A Review of Laparoscopic Sleeve Gastrectomy for Morbid Obesity
- (2010) Xinzhe Shi et al. OBESITY SURGERY
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases
- (2009) Alexei Kharitonenkov et al. BIODRUGS
- Fibroblast Growth Factor 21 Regulates Lipolysis in White Adipose Tissue But Is Not Required for Ketogenesis and Triglyceride Clearance in Liver
- (2009) Yuhei Hotta et al. ENDOCRINOLOGY
- Fibroblast Growth Factor 19 Serum Levels: Relation to Renal Function and Metabolic Parameters
- (2009) M. Reiche et al. HORMONE AND METABOLIC RESEARCH
- Metabolic surgery and gut hormones – A review of bariatric entero-humoral modulation
- (2009) Hutan Ashrafian et al. PHYSIOLOGY & BEHAVIOR
- Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity
- (2008) M. Mraz et al. CLINICAL ENDOCRINOLOGY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis
- (2008) Frank G. Schaap et al. HEPATOLOGY
- Plasma Concentrations of Fibroblast Growth Factors 19 and 21 in Patients with Anorexia Nervosa
- (2008) Ivana Dostálová et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now